SF Prep

NPPA notifies 30% trade margin cap on 137 non-scheduled anti-cancer drugs; revised prices from 9 November 2026

On 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) notified Trade Margin Rationalisation for 137 non-scheduled anti-cancer drugs, capping trade margin at 30% of MRP, with revised prices effective from 9 November 2026.

Summary

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has notified Trade Margin Rationalisation (TMR) for 137 non-scheduled anti-cancer drugs by a Gazette notification dated 17 October 2026. Trade margin has been capped at 30% of the MRP under Paragraph 19 of the Drugs (Prices Control) Order, 2013, which is expected to cut MRPs by up to 70%. The list was recommended by an Expert Committee under the DGHS, and builds on NPPA's 2019 pilot covering 42 anti-cancer drugs. Revised prices take effect from 9 November 2026.

Key facts

Authority
National Pharmaceutical Pricing Authority (NPPA), Dept of Pharmaceuticals
Drugs covered
137 non-scheduled anti-cancer drugs
Trade margin cap
30% of MRP
Legal basis
Paragraph 19, Drugs (Prices Control) Order, 2013
Expected MRP cut
Up to 70%
Gazette notification
17 October 2026
Revised prices effective
9 November 2026
2019 pilot
42 anti-cancer drugs; MRP of 526 brands cut by up to 90%
Price check app
Pharma Sahi Daam

Practice MCQs 3 questions

Q1

In October 2026, NPPA notified Trade Margin Rationalisation for how many non-scheduled anti-cancer drugs?

Show answer

Correct answer: A — 137

PIB: NPPA undertook Trade Margin Rationalisation of 137 identified non-scheduled anti-cancer drugs.
Q2 Advanced

From which date will the revised prices of 137 anti-cancer drugs under NPPA's October 2026 Trade Margin Rationalisation take effect?

Show answer

Correct answer: B — 9 November 2026

PIB: The revised prices will become effective from 9 November 2026; manufacturers must inform NPPA within 7 days of the Gazette notification.
Q3 Advanced

Consider the following statements about NPPA's October 2026 Trade Margin Rationalisation (TMR) of anti-cancer drugs: 1. It was notified under Paragraph 19 of the Drugs (Prices Control) Order, 2013. 2. It builds on a 2019 pilot TMR that covered 42 anti-cancer drugs. Which of the statements given above is/are correct?

Show answer

Correct answer: C — Both 1 and 2

PIB: The trade margin was capped under Paragraph 19 of DPCO, 2013, and the exercise builds on NPPA's 2019 pilot TMR covering 42 anti-cancer drugs. So both statements are correct.

← All current affairs